5-Methycytosine and 5-Hydroxymethylcytosine in Psychiatric Epigenetics

Epigenetics in Psychiatry

Volumn , Issue , 2014, Pages 209-240

  Grayson, Dennis R ^a   Guidotti, Alessandro ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Autism; Base excision repair; Biomarker; Bipolar disorder; Demethylation; Epigenetics; Hydroxymethylation; Lymphocyte; Major depression; Methylation; Next generation sequencing; Psychosis; Schizophrenia; Ten eleven hydroxylase

Indexed keywords

EID: 84942843499     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-417114-5.00010-3     Document Type: Chapter

References (155)

1. Waddington CH The strategy of the genes 1957, Allen & Unwin, London.
2. Slack JMW Conrad Hal Waddington: the last Renaissance biologist?. Nat Rev Genet 2002, 3:889-895.
3. Ptashne M Epigenetics: core misconcept. Proc Natl Acad Sci USA 2013, 110:7101-7103.
4. Gottesman II, Shields J, Hanson DR Schizophrenia: the epigenetic puzzle 1982, Cambridge University Press, Cambridge.
5. Petronis A, Paterson AD, Kennedy JL Schizophrenia: an epigenetic puzzle?. Schizophr Bull 1999, 25:639-655.
6. Petronis A Human morbid genetics revisited: relevance of epigenetics. Trends Genet 2001, 17:142-146.
7. Millan M An epigenetic framework for neurodevelopmental disorders: from pathogenesis to potential therapy. Neuropharmacology 2013, 68:2-82.
8. Hompes T, Izzi B, Gellens E, Morreels M, Fieuws S, Pexsters A, et al. Investigating the influence of maternal cortisol and emotional state during pregnancy on the DNA methylation status of the glucocorticoid receptor gene (NR3C1) promoter region in cord blood. J Psychiatr Res 2013, 47:880-891.
9. Weaver IC, Cervoni N, Champagne FA, D'Alessio AC, Sharma S, Seckl JR, et al. Epigenetic programming by maternal behavior. Nat Neurosci 2004, 7:847-854.
10. McGowan PO, Sasaki A, D'Alessio AC, Dymov S, Labonté B, Szyf M, et al. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci 2009, 12:342-348.
11. Lutz PE, Turecki G. DNA methylation and childhood maltreatment: from animal models to human studies. Neuroscience 2014;264:142-56.
12. Bhutani N, Burns DM, Blau HM DNA demethylation dynamics. Cell 2011, 146:866-872.
13. Grayson DR, Guidotti A The dynamics of DNA methylation in schizophrenia and related psychiatric disorders. Neuropsychopharmacology 2012, 38:138-166.
14. Shen L, Zhang Y 5-Hydroxymethylcytosine: generation, fate, and genomic distribution. Curr Opin Cell Biol 2013, 25:289-296.
15. Wang T, Pan Q, Lin L, Szulwach KE, Song CX, He C, et al. Genome-wide DNA hydroxymethylation changes are associated with neurodevelop-mental genes in the developing human cerebellum. Hum Mol Genet 2012, 21:5500-5510.
16. Zemach A, McDaniel E, Zilberman D Genome-wide evolutionary analysis of eukaryotic DNA methylation. Science 2010, 328:916-919.
17. Jeltsch A Phylogeny of methylomes. Science 2010, 328:837-838.
18. Robertson KD, Jones PA DNA methylation: past, present, and future directions. Carcinogenesis 2000, 21:461-467.
19. Bestor T DNA methylation: evolution of a bacterial immune function into a regulator of gene expression and genome structure in higher eukaryotes. Philos Trans R Soc Lond B Biol Sci 1990, 326:179-187.
20. Xie W, Barr CL, Kim A, Yue F, Lee AY, Eubanks J, et al. Base-resolution analyses of sequence and parent-of-origin dependent DNA methylation in the mouse genome. Cell 2012, 148:816-831.
21. Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, Tonti-Filippini J, et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 2009, 462:315-322.
22. McClelland M, Ivarie R Asymmetrical distribution of CpG in an "average" mammalian gene. Nucleic Acids Res 1982, 10:7865-7877.
23. Gardiner-Gardin M, Frommer M CpG islands in vertebrate genomes. J Mol Biol 1987, 196:261-282.
24. Bird A DNA methylation patterns and epigenetic memory. Genes Dev 2002, 16:6-21.
25. Illingworth RS, Bird A CpG islands-"a rough guide.". FEBS Lett 2009, 583:1713-1720.
26. Chen ZX, Riggs AD DNA methylation and demethylation in mammals. J Biol Chem 2011, 286:18347-18353.
27. Irizarry RA, Ladd-Acosta C, Wen B, Wu Z, Montano C, Onyango P, et al. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet 2009, 41:178-186.
28. Stein R, Gruenbaum Y, Pollack Y, Razin A, Cedar H Clonal inheritance of the pattern of DNA methylation in mouse cells. Proc Natl Acad Sci USA 1982, 79:61-65.
29. Moore LD, Le T, Fan G DNA methylation and its basic function. Neuropsychopharmacology 2013, 38:23-38.
30. Robertson KD, Ambinder RF Mapping promoter regions that are hypersensitive to methylation-mediated inhibition of transcription: application of the methylation cassette assay to the Epstein-Barr virus major latency promoter. J Virol 1997, 71:6445-6454.
31. Boyes J, Bird A Repression of genes by DNA methylation depends on CpG density and promoter strength: evidence for involvement of a methyl-CpG binding protein. EMBO J 1992, 11:327-333.
32. Jurkowska RZ, Jurkowski TP, Jeltsch A Structure and function of mammalian DNA methyltransferases. Chem Biochem 2011, 12:206-222.
33. Chédin F The DNMT3 family of mammalian de novo DNA methyltransferases. Prog Mol Biol Transl Sci 2011, 101:255-285.
34. Jin B, Li Y, Robertson KD DNA methylation: superior or subordinate in the epigenetic hierarchy?. Genes Cancer 2011, 2:607-617.
35. Neri F, Krepelova A, Incarnato D, Maldotti M, Parlato C, Galvagni F, et al. Dnmt3L antagonizes DNA methylation at bivalent promoters and favors DNA methylation at gene bodies in ESCs. Cell 2013, 155:121-134.
36. Feng J, Chang H, Li E, Fan G Dynamic expression of de novo DNA methyltransferases Dnmt3a and Dnmt3b in the central nervous system. J Neurosci Res 2005, 79:734-746.
37. Cardoso MC, Leonhardt H DNA methyltransferase is actively retained in the cytoplasm during early development. J Cell Biol 1999, 147:25-32.
38. Hermann A, Gowher H, Jeltsch A Biochemistry and biology of mammalian DNA methyltransferases. Cell Mol Life Sci 2004, 61:2571-2587.
39. Jeltsch A On the enzymatic properties of Dnmt1: specificity, processivity, mechanism of linear diffusion and allosteric regulation of the enzyme. Epigenetics 2006, 1:63-66.
40. Fatemi M, Hermann A, Gowher H, Jeltsch A Dnmt3a and Dnmt1 functionally cooperate during de novo methylation of DNA. Eur J Biochem 2002, 269:4981-4984.
41. Dhe-Paganon S, Syeda F, Park L DNA methyl transferase 1: regulatory mechanisms and implications in health and disease. Int J Biochem Mol Biol 2011, 2:58-66.
42. Hashimoto H, Vertino PM, Cheng X Molecular coupling of DNA methylation and histone methylation. Epigenomics 2010, 2:657-669.
43. Espada J Non-catalytic functions of DNMT1. Epigenetics 2012, 7:115-118.
44. Clements EG, Mohammad HP, Leadem BR, Easwaran H, Cai Y, Van Neste L, et al. DNMT1 modulates gene expression without its catalytic activity partially through its interactions with histone-modifying enzymes. Nucleic Acids Res 2012, 40:4334-4346.
45. Jin B, Ernst J, Tiedemann RL, Xu H, Sureshchandra S, Kellis M, et al. Linking DNA methyltransferases to epigenetic marks and nucleosome structure genome-wide in human tumor cells. Cell Rep 2012, 2:1411-1424.
46. Maunakea AK, Nagarajan RP, Bilenky M, Ballinger TJ, D'Souza C, Fouse SD, et al. Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature 2010, 466:253-257.
47. Veldic M, Guidotti A, Maloku E, Davis JM, Costa E In psychosis, cortical interneurons overexpress DNA-methyltransferase I. Proc Natl Acad Sci USA 2005, 102:2152-2157.
48. Veldic M, Kadriu B, Maloku E, Agis-Balboa RC, Guidotti A, Davis JM, et al. Epigenetic mechanisms expressed in basal ganglia GABAergic neurons differentiate schizophrenia from bipolar disorder. Schizophr Res 2007, 91:51-61.
49. Pesold C, Liu WS, Guidotti A, Costa E, Caruncho HJ Cortical bitufted, horizontal, and Martinotti cells preferentially express and secrete reelin into perineuronal nets, nonsynaptically modulating gene expression. Proc Natl Acad Sci USA 1999, 96:3217-3222.
50. Kadriu B, Guidotti A, Chen Y, Grayson DR The DNA methyltransferases 1 (DNMT1) and 3a (DNMT3a) co-localize with GAD67-positive neurons in the GAD67-GFP mouse brain. J Comp Neurol 2012, 520:1951-1964.
51. Zhubi A, Veldic M, Puri NV, Kadriu B, Caruncho H, Loza I, et al. An up-regulation of DNA-methyltransferase 1 and 3a expressed in telencephalic GABAergic neurons of schizophrenia patients is also detected in peripheral blood lymphocytes. Schizophrenia Res 2009, 111:115-122.
52. Ruzika W, Zhubi A, Veldic M, Grayson DR, Costa E, Guidotti A Selective epigenetic alteration of layer I GABAergic neurons isolated from prefrontal cortex of schizophrenia patients using laser-assisted microdissection. Mol Psychiatry 2007, 12:385-397.
53. Abdolmaleky HM, Cheng KH, Russo A, Smith CL, Faraone SV, Wilcox M, et al. Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report. Am J Med Genet B Neuropsychiatr Genet 2005, 134:60-66.
54. Grayson DR, Jia X, Chen Y, Sharma RP, Mitchell CP, Guidotti A, et al. Reelin promoter hypermethylation in schizophrenia. Proc Natl Acad Sci USA 2005, 102:9341-9346.
55. Auta J, Smith RC, Dong E, Tueting P, Sershen H, Boules S, et al. DNA-methylation gene network dysregulation in peripheral blood lymphocytes of schizophrenia patients. Schizophr Res 2013, 150:312-318.
56. Powell TR, Smith RG, Hackinger S, Schalkwyk LC, Uher R, McGuffin P, et al. DNA methylation in interleukin-11 predicts clinical response to antidepressants in GENDEP. Transl Psychiatry 2013, 3:e300.
57. Aberg KA, Xie LY, McClay JL, Nerella S, Vunck S, Snider S, et al. Testing two models describing how methylome-wide studies in blood are informative for psychiatric conditions. Epigenomics 2013, 5:367-377.
58. Melas PA, Rogdaki M, Ösby U, Schalling M, Lavebratt C, Ekström TJ Epigenetic aberrations in leukocytes of patients with schizophrenia: association of global DNA methylation with antipsychotic drug treatment and disease onset. FASEB J 2012, 26:2712-2718.
59. Niwa M, Jaaro-Peled H, Tankou S, Seshadri S, Hikida T, Matsumoto Y, et al. Adolescent stress-induced epigenetic control of dopaminergic neurons via glucocorticoids. Science 2013, 339:335-339.
60. Frommer M, McDonald LE, Millar DS, Collis CM, Watt F, Grigg GW, et al. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci USA 1992, 89:1827-1831.
61. Huang Y, Pastor WA, Shen Y, Tahiliani M, Liu DR, Rao A The behaviour of 5-hydroxy methylcytosine in bisulfite sequencing. PLoS ONE 2010, 5:e8888.
62. Pastor WA, Huang Y, Henderson HR, Agarwal S, Rao A The GLIB technique for genome-wide mapping of 5-hydroxymethylcytosine. Nat Protoc 2012, 7:1909-1917.
63. Marabita F, Almgren M, Lindholm ME, Ruhrmann S, Fagerström-Billai F, Jagodic M, et al. An evaluation of analysis pipelines for DNA methylation profiling using the Illumina HumanMethylation450 BeadChip platform. Epigenetics 2013, 8:333-346.
64. Lister R, Mukamel EA, Nery JR, Urich M, Puddifoot CA, Johnson ND, et al. Global epigenomic reconfiguration during mammalian brain development. Science 2013, 341:1237905.
65. Hawkins RD, Hon GC, Ren B Next-generation genomics: an integrative approach. Nat Rev Genet 2010, 11:476-486.
66. Booth MJ, Ost TW, Beraldi D, Bell NM, Branco MR, Reik W, et al. Oxidative bisulfite sequencing of 5-methylcytosine and 5-hydroxymethylcytosine. Nat Protoc 2013, 8:1841-1851.
67. Bassil CF, Huang Z, Murphy SK Bisulfite pyrosequencing. Methods Mol Biol 2013, 1049:95-107.
68. van den Boom D, Ehrich M Mass spectrometric analysis of cytosine methylation by base-specific cleavage and primer extension methods. Methods Mol Biol 2009, 507:207-227.
69. Yu M, Hon GC, Szulwach KE, Song CX, Jin P, Ren B, et al. Tet-assisted bisulfite sequencing of 5-hydroxymethylcytosine. Nat Protoc 2012, 7:2159-2170.
70. Costello JF, Krzywinski M, Marra MA A first look at entire human methylomes. Nat Biotechnol 2009, 27:1130-1132.
71. Ziller MJ, Gu H, Müller F, Donaghey J, Tsai LT, Kohlbacher O, et al. Charting a dynamic DNA methylation landscape of the human genome. Nature 2013, 500:477-481.
72. Kriaucionis S, Heintz N The nuclear base 5-hyrdoxymethylcytosine is present in Purkinje neurons and the brain. Science 2009, 324:929-930.
73. Doi A, Park IH, Wen B, Murakami P, Aryee MJ, Irizarry R, et al. Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat Genet 2009, 41:1350-1353.
74. Vanderkraats ND, Hiken JF, Decker KF, Edwards JR Discovering high-resolution patterns of differential DNA methylation that correlate with gene expression changes. Nucleic Acids Res 2013, 41:6816-6827.
75. Heyn H, Esteller M DNA methylation profiling in the clinic: applications and challenges. Nat Rev Genet 2012, 13:679-692.
76. Dedeurwaerder S, Defrance M, Calonne E, Denis H, Sotiriou C, Fuks F Evaluation of the Infinium Methylation 450K technology. Epigenomics 2011, 3:771-784.
77. Bibikova M, Barnes B, Tsan C, Ho V, Klotzle B, Le JM, et al. High density DNA methylation array with single CpG site resolution. Genomics 2011, 98:288-295.
78. Pidsley R, Wong CC, Volta M, Lunnon K, Mill J, Schalkwyk LC A data-driven approach to preprocessing Illumina 450K methylation array data. BMC Genomics 2013, 14:293.
79. Guintivano J, Aryee MJ, Kaminsky ZA A cell epigenotype specific model for the correction of brain cellular heterogeneity bias and its application to age, brain region and major depression. Epigenetics 2013, 8:290-302.
80. Fouse SD, Nagarajan RO, Costello JF Genome-scale DNA methylation analysis. Epigenomics 2010, 2:105-117.
81. Harris RA, Wang T, Coarfa C, Nagarajan RP, Hong C, Downey SL, et al. Comparison of sequencing-based methods to profile DNA methylation and identification of monoallelic epigenetic modifications. Nat Biotechnol 2010, 28:1097-1105.
82. Wheeler DA, Srinivasan M, Egholm M, Shen Y, Chen L, McGuire A, et al., et al. The complete genome of an individual by massively parallel DNA sequencing. Nature 2008, 452:872-876.
83. Martinowich K, Hattori D, Wu H, Fouse S, He F, Hu Y, et al. DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science 2003, 302:890-893.
84. Chen WG, Chang Q, Lin Y, Meissner A, West AE, Griffith EC, et al. Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 2003, 302:885-889.
85. Pruunsild P, Kazantseva A, Aid T, Palm K, Timmusk T Dissecting the human BDNF locus: bidirectional transcription, complex splicing, and multiple promoters. Genomics 2007, 90:397-406.
86. Wong J, Webster MJ, Cassano H, Weickert CS Changes in alternative brain-derived neurotrophic factor transcript expression in the developing human prefrontal cortex. Eur J Neurosci 2009, 29:1311-1322.
87. Aid T, Kazantseva A, Piirsoo M, Palm K, Timmusk T Mouse and rat BDNF gene structure and expression revisited. J Neurosci Res 2007, 85:525-535.
88. Wong J, Hyde TM, Cassano HL, Deep-Soboslay A, Kleinman JE, Weickert CS Promoter specific alterations of brain-derived neurotrophic factor mRNA in schizophrenia. Neuroscience 2010, 169:1071-1084.
89. Mill J, Tang T, Kaminsky Z, Khare T, Yazdanpanah S, Bouchard L, et al. Epigenomic profiling reveals DNA-methylation changes associated with major psychosis. Am J Hum Genet 2008, 82:696-711.
90. Shimizu E, Hashimoto K, Okamura N, Koike K, Komatsu N, Kumakiri C, et al. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 2003, 54:70-75.
91. Sen S, Duman R, Sanacora G Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry 2008, 64:527-532.
92. Fuchikami M, Morinobu S, Segawa M, Okamoto Y, Yamawaki S, Ozaki N, et al. DNA methylation profiles of the brain-derived neurotrophic factor (BDNF) gene as a potent diagnostic biomarker in major depression. PLoS ONE 2011, 6:e23881.
93. Tadic A, Müller-Engling L, Schlicht KF, Kotsiari A, Dreimüller N, Kleimann A, et al. Methylation of the promoter of brain-derived neurotrophic factor exon IV and antidepressant response in major depression. Mol Psychiatry 2013, 19:281-283.
94. Ikegame T, Bundo M, Murata Y, Kasai K, Kato T, Iwamoto K DNA methylation of the BDNF gene and its relevance to psychiatric disorders. J Hum Genet 2013, 58:434-438.
95. Weickert CS, Hyde TM, Lipska BK, Herman MM, Weinberger DR, Kleinman JE Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Mol Psychiatry 2003, 8:592-610.
96. Ikegame T, Bundo M, Sunaga F, Asai T, Nishimura F, Yoshikawa A, et al. DNA methylation analysis of BDNF gene promoters in peripheral blood cells of schizophrenia patients. Neurosci Res 2013, 77:208-214.
97. Gavin DP, Sharma RP, Chase KA, Matrisciano F, Dong E, Guidotti A Growth arrest and DNA-damage-inducible, beta (GADD45b)-mediated DNA demethylation in major psychosis. Neuropsychopharmacology 2012, 37:531-542.
98. Keller S, Sarchiapone M, Zarrilli F, Videtic A, Ferraro A, Carli V, et al. Increased BDNF promoter methylation in the Wernicke area of suicide subjects. Arch Gen Psychiatry 2010, 67:258-267.
99. Schumacher A, Kapranov P, Kaminsky Z, Flanagan J, Assadzadeh A, Yau P, et al. Microarray-based DNA methylation profiling: technology and applications. Nucleic Acids Res 2006, 34:528-542.
100. Ira E, Zanoni M, Ruggeri M, Dazzan P, Tosato S COMT, neuropsychological function and brain structure in schizophrenia: a systematic review and neurobiological interpretation. J Psychiatry Neurosci 2013, 38:120178.
101. Dempster E, Viana J, Pidsley R, Mill J Epigenetic studies of schizophrenia: progress, predicaments, and promises for the future. Schizophr Bull 2013, 39:11-16.
102. Liu J, Chen J, Ehrlich S, Walton E, White T, Perrone-Bizzozero N, et al.. Methylation patterns in whole blood correlate with symptoms in schizophrenia patients. Schizophr Bull (in press).
103. Nishioka M, Bundo M, Koike S, Takizawa R, Kakiuchi C, Araki T, et al. Comprehensive DNA methylation analysis of peripheral blood cells derived from patients with first-episode schizophrenia. J Hum Genet 2013, 58:91-97.
104. Carrard A, Salzmann A, Malafosse A, Karege F Increased DNA methylation status of the serotonin receptor 5HTR1A gene promoter in schizophrenia and bipolar disorder. J Affect Disord 2011, 132:450-453.
105. Ghadirivasfi M, Nohesara S, Ahmadkhaniha HR, Eskandari MR, Mostafavi S, Thiagalingam S, et al. Hypomethylation of the serotonin receptor type-2A Gene (HTR2A) at T102C polymorphic site in DNA derived from the saliva of patients with schizophrenia and bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 2011, 156B:536-545.
106. Nohesara S, Ghadirivasfi M, Mostafavi S, Eskandari MR, Ahmadkhaniha H, Thiagalingam S, et al. DNA hypomethylation of MB-COMT promoter in the DNA derived from saliva in schizophrenia and bipolar disorder. J Psychiatr Res 2011, 45:1432-1438.
107. Dempster EL, Pidsley R, Schalkwyk LC, Owens S, Georgiades A, Kane F, et al. Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder. Hum Mol Genet 2011, 20:4786-4796.
108. Xu B, Roos JL, Dexheimer P, Boone B, Plummer B, Levy S, et al. Exome sequencing supports a de novo mutational paradigm for schizophrenia. Nat Genet 2011, 43:864-868.
109. Kinoshita M, Numata S, Tajima A, Shimodera S, Ono S, Imamura A, et al. DNA methylation signatures of peripheral leukocytes in schizophrenia. Neuromolecular Med 2013, 15:95-101.
110. Reinius LE, Acevedo N, Joerink M, Pershagen G, Dahlén SE, Greco D, et al. Differential DNA methylation in purified human blood cells: implications for cell lineage and studies on disease susceptibility. PLoS ONE 2012, 7:e41361.
111. Dong E, Nelson M, Grayson DR, Costa E, Guidotti A Clozapine and sulpiride but not haloperidol or olanzapine activate brain DNA demethylation. Proc Natl Acad Sci USA 2008, 105:13614-13619.
112. Guidotti A, Dong E, Kundakovic M, Satta R, Grayson DR, Costa E Characterization of the action of antipsychotic subtypes on valproate-induced chromatin remodeling. Trends Pharmacol Sci 2009, 30:55-60.
113. Dempster E, Viana J, Pidsley R, Mill J Epigenetic studies of schizophrenia: progress, predicaments, and promises for the future. Schizophr Bull 2013, 39:11-16.
114. Nair SS, Coolen MW, Stirzaker C, Song JZ, Statham AL, Strbenac D, et al. Comparison of methyl-DNA immunoprecipitation (MeDIP) and methyl-CpG binding domain (MBD) protein capture for genome-wide DNA methylation analysis reveal CpG sequence coverage bias. Epigenetics 2011, 6:34-44.
115. Aberg KA, McClay JL, Nerella S, Xie LY, Clark SL, Hudson AD, et al. MBD-seq as a cost-effective approach for methylome-wide association studies: demonstration in 1500 case-control samples. Epigenomics 2012, 4:605-621.
116. McClay JL, Aberg KA, Clark SL, Nerella S, Kumar G, Xie LY, et al. A methylome-wide study of aging using massively parallel sequencing of the methyl-CpG-enriched genomic fraction from blood in over 700 subjects. Hum Mol Genet 2013, 23:1175-1185.
117. Hollegaard MV, Grauholm J, Nielsen R, Grove J, Mandrup S, Hougaard DM Archived neonatal dried blood spot samples can be used for accurate whole genome and exome-targeted next-generation sequencing. Mol Genet Metab 2013, 110:65-72.
118. Li Y, Zhu J, Tian G, Li N, Li Q, Ye M, et al. The DNA methylome of human peripheral blood mononuclear cells. PLoS Biol 2010, 8:e1000533.
119. Davies MN, Volta M, Pidsley R, Lunnon K, Dixit A, Lovestone S, et al. Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood. Genome Biol 2012, 13:R43.
120. Gregory SG, Connelly JJ, Towers AJ, Johnson J, Biscocho D, Markunas CA, et al. Genomic and epigenetic evidence for oxytocin receptor deficiency in autism. BMC Med 2009, 7:62.
121. Uchino S, Waga C SHANK3 as an autism spectrum disorder-associated gene. Brain Dev 2013, 35:106-110.
122. LaSalle JM A genomic point-of-view on environmental factors influencing the human brain methylome. Epigenetics 2011, 6:862-869.
123. Siniscalco D, Cirillo A, Bradstreet JJ, Antonucci N Epigenetic findings in autism: new perspectives for therapy. Int J Environ Res Public Health 2013, 10:4261-4273.
124. Mellén M, Ayata P, Dewell S, Kriaucionis S, Heintz N MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system. Cell 2012, 151:1417-1430.
125. Zhubi A, Chen Y, Dong E, Cook EH, Guidotti A, Grayson DR Increased binding of MeCP2 to the GAD1 and RELN promoters may be mediated by an enrichment of 5-hmC in autism spectrum disorder (ASD) cerebellum. Transl Psychiatry 2014, 4:e349.
126. Wong CC, Meaburn EL, Ronald A, Price TS, Jeffries AR, Schalkwyk LC, et al.. Methylomic analysis of monozygotic twins discordant for autism spectrum disorder and related behavioural traits. Mol Psychiatry 2014;19:495-503.
127. Ladd-Acosta C, Hansen KD, Briem E, Fallin MD, Kaufmann WE, Feinberg AP. Common DNA methylation alterations in multiple brain regions in autism. Mol Psychiatry (in press).
128. Jaffe AE, Murakami P, Lee H, Leek JT, Fallin MD, Feinberg AP, et al. Bump hunting to identify differentially methylated regions in epigenetic epidemiology studies. Int J Epidemiol 2012, 41:200-209.
129. Sabunciyan S, Aryee MJ, Irizarry RA, Rongione M, Webster MJ, Kaufman WE, et al. Genome-wide DNA methylation scan in major depressive disorder. PLoS ONE 2012, 7:e34451.
130. Wyatt GR, Cohen SS The bases of the nucleic acids of some bacterial and animal viruses: the occurrence of 5-hydroxymethylcytosine. Biochem J 1953, 55:774-782.
131. Hershey AD, Dixon J, Chase M Nucleic acid economy in bacteria infected with bacteriophage T2. I. Purine and pyrimidine composition. J Gen Physiol 1953, 36:777-789.
132. Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, Brudno Y, et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009, 324:930-935.
133. Münzel M, Globisch D, Carell T 5-Hydroxymethylcytosine, the sixth base of the genome. Angew Chem Int Ed Engl 2011, 50:6460-6468.
134. Ito S, Shen L, Dai Q, Wu SC, Collins LB, Swenberg JA, et al. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 2011, 333:1300-1303.
135. Cortellino S, Xu J, Sannai M, Moore R, Caretti E, Cigliano A, et al. Thymine DNA glycosylase is essential for active DNA demethylation by linked deamination-base excision repair. Cell 2011, 146:67-79.
136. Hashimoto H, Hong S, Bhagwat AS, Zhang X, Cheng X Excision of 5-hydroxymethyluracil and 5-carboxylcytosine by the thymine DNA glycosylase domain: its structural basis and implications for active DNA demethylation. Nucleic Acids Res 2012, 40:10203-10214.
137. Yu M, Hon GC, Szulwach KE, Song CX, Zhang L, Kim A, et al. Base-resolution analysis of 5-hydroxymethylcytosine in the mammalian genome. Cell 2012, 149:1368-1380.
138. Stroud H, Feng S, Morey Kinney S, Pradhan S, Jacobsen SE 5-Hydroxymethylcytosine is associated with enhancers and gene bodies in human embryonic stem cells. Genome Biol 2011, 12:R54.
139. Wu H, D'Alessio AC, Ito S, Wang Z, Cui K, Zhao K, et al. Genome-wide analysis of 5-hydroxymethylcytosine distribution reveals its dual function in transcriptional regulation in mouse embryonic stem cells. Genes Dev 2011, 25:679-684.
140. Williams K, Christensen J, Pedersen MT, Johansen JV, Cloos PA, Rappsilber J, et al. TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity. Nature 2011, 473:343-348.
141. Williams K, Christensen J, Helin K DNA methylation: TET proteins-guardians of CpG islands?. EMBO Rep 2011, 13:28-35.
142. Bhutani N, Burns DM, Blau HM DNA demethylation dynamics. Cell 2011, 146:866-872.
143. Song CX, He C Potential functional roles of DNA demethylation intermediates. Trends Biochem Sci 2013, 38:480-484.
144. Thambirajah AA, Ng MK, Frehlick LJ, Li A, Serpa JJ, Petrotchenko EV, et al. MeCP2 binds to nucleosome free (linker DNA) regions and to H3K9/H3K27 methylated nucleosomes in the brain. Nucleic Acids Res 2012, 40:2884-2897.
145. Spruijt CG, Gnerlich F, Smits AH, Pfaffeneder T, Jansen PW, Bauer C, et al. Dynamic readers for 5-(hydroxy)methylcytosine and its oxidized derivatives. Cell 2013, 152:1146-1159.
146. Dong E, Gavin DP, Chen Y, Davis J Upregulation of TET1 and downregulation of APOBEC3A and APOBEC3C in the parietal cortex of psychotic patients. Transl Psychiatry 2012, 2:e159.
147. Di Ruscio A, Ebralidze AK, Benoukraf T, Amabile G, Goff LA, Terragni J, et al. DNMT1-interacting RNAs block gene-specific DNA methylation. Nature 2013, 503:371-376.
148. Li Y, Wang H, Muffat J, Cheng AW, Orlando DA, Lovén J, et al. Global transcriptional and translational repression in human-embryonic-stem-cell-derived Rett syndrome neurons. Cell Stem Cell 2013, 13:446-458.
149. Chen CC, Wang KY, Shen CK DNA 5-methylcytosine demethylation activities of the mammalian DNA methyltransferases. J Biol Chem 2013, 288:9084-9091.
150. Wu H, Zhang Y Mechanisms and functions of Tet protein-mediated 5-methylcytosine oxidation. Genes Dev 2011, 25:2436-2452.
151. Ma DK, Jang MH, Guo JU, Kitabatake Y, Chang ML, Pow-Anpongkul N, et al. Neuronal activity-induced Gadd45b promotes epigenetic DNA demethylation and adult neurogenesis. Science 2009, 323:1074-1077.
152. Chen Y, Sharma RP, Costa RH, Costa E, Grayson DR On the epigenetic regulation of the human reelin promoter. Nucleic Acids Res 2002, 30:2930-2939.
153. Kar S, Deb M, Sengupta D, Shilpi A, Parbin S, Torrisani J, et al. An insight into the various regulatory mechanisms modulating human DNA methyltransferase 1 stability and function. Epigenetics 2012, 7:994-1007.
154. Song J, Rechkoblit O, Bestor TH, Patel DJ Structure of DNMT1-DNA complex reveals a role for autoinhibition in maintenance DNA methylation. Science 2011, 331:1036-1040.
155. Zweig AS, Karolchik D, Kuhn RM, Haussler D, Kent WJ UCSC genome browser tutorial. Genomics 2008, 92:75-84.